Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 71610-518

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 71610-518). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 500 mg (71610 0518 83)

Ranolazine ER 500 mg extended-release tablets label shows packaging for 3600 tablets. The label includes the product name Ranolazine ER, strength 500 mg, tablet quantity 3600, and manufacturer information listing SunGen Pharma, LLC of Princeton, NJ, with repackaging by Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN. It also displays storage instructions, batch and lot numbers, and indicates the product is for prescription use only (RX Only).*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structure (Structure)

Chemical structure diagram of the active ingredient Ranolazine, showing its molecular connectivity and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.